CLINICAL_TRIALS
trial_result
· 2024-04-19
Clinical Trial Update: Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
Summary
Clinical trial update reporting adherence to nintedanib among patients with idiopathic pulmonary fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED | Results posted: 2024-04-19